Date:
Thursday, October 31, 2019, 4:15pm to 6:15pm
Location:
Pfizer Lecture Hall
Professor Daniel Nomura, University of California, Berkeley. "Reimagining Druggability Using Chemoproteomic Platforms."
Dr. David Edmonds, Pfizer, Inc.: "Discovery of PF-06882961: A potent, orally bioavailable small molecule agonist of the GLP-1 Receptor."
See also: Pfizer Symposium